Table 3

Results of multiple moderator analyses for Pe

Pe
ModeratorCategories (k)SMD (95% CI)QI2p value
Clinical diagnosis groupChild ADHD (7)−0.39 (−0.70 to −0.08)6.040%0.42
Adult ADHD (8)−0.56 (−1.15 to 0.04)28.8676%< 0.01
Clinical addiction (5)−0.15 (−0.66 to 0.36)6.8141%0.15
Subclinical addiction (5)−0.09 (−0.40 to 0.23)5.915%0.30
Other (6)−0.08 (−0.55 to 0.40)6.1435%0.19
ComorbidityYes, mixed (4)−0.23 (−0.85 to 0.40)6.5954%0.09
Yes, internalizing (2)
Yes, externalizing (19)−0.07 (−0.48 to 0.34)9.6548%0.09
No (6)−0.28 (−0.47 to −0.10)23.8424%0.16
Experimental paradigmFlanker (22)−0.15 (−0.33 to 0.04)36.0142%0.02
Go/no-go (9)−0.53 (−0.92 to −0.15)17.1453%0.03
Performance feedbackYes (20)−0.16 (−0.34 to 0.02)28.4033.1%0.08
No (11)−0.47 (−0.86 to −0.08)30.0866.8%< 0.01
  • ADHD = attention-deficit/hyperactivity disorder; CI = confidence interval; k = number of studies included in the model; Pe = error positivity; SMD = standardized mean difference.

  • Random models with moderators for Pe studies, except for internalizing comorbidity (fewer than 3 studies). We performed subsequent analyses to investigate the effect of other midline electrode sites Fz and Cz (Appendix 1, Section 4).